"Executive Summary:                    The single-cell genome sequencing-based cancer market is rapidly expanding, driven by advancements in genomic technologies, rising cancer prevalence, and growing demand for personalized treatments. Single-cell genome sequencing has primarily been utilized in cancer research to examine critical factors such...